Literature DB >> 32430545

[Percutaneous liver biopsy before organ removal-Impact on organ allocation and costs in liver transplantation].

Christian Beltzer1, Markus Quante1, Myriam Rheinberger1, Hideo Andreas Baba2, Fuat Saner3, Falko Fend4, Thomas Biet5, Alfred Königsrainer1, Silvio Nadalin6.   

Abstract

BACKGROUND: The value and safety of percutaneous liver biopsy (PLB) in brain-dead donors before organ removal and its impact on organ allocation and costs of liver transplantation (LT) in the Eurotransplant (ET) region is still a matter of ongoing debate.
MATERIAL AND METHODS: A PLB was performed in 36 brain-dead organ donors. The complication rate, ultrasonography findings, macroscopic evaluation and histological results of PLB and donor characteristics were analyzed. Additionally, a nationwide survey was conducted among 11 liver transplantation experts. The need for PLB and its impact on the liver allocation process were evaluated. Possible cost savings were calculated for different scenarios based on cost data provided by the German Organ Transplantation Foundation.
RESULTS: No complications of PLB were observed. The survey revealed that the PLB has a substantial impact on the allocation of donor organs, especially in organs fulfilling extended donor criteria (EDC). The cost calculation revealed an enormous potential for cost savings due to an optimized organ allocation process and avoidance of futile organ procurement.
CONCLUSION: The PLB is a safe procedure and has tremendous potential for the optimization of the organ allocation process before organ procurement by reducing the cold ischemia time, avoiding unnecessarily discarding donor organs and saving costs. These data emphasize the clinical relevance and impact of PLB on the organ allocation process.

Entities:  

Keywords:  Cold ischemia time; Donor evaluation; Extended donor criteria; Liver steatosis

Mesh:

Year:  2021        PMID: 32430545      PMCID: PMC7820082          DOI: 10.1007/s00104-020-01192-w

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  48 in total

1.  EASL Clinical Practice Guidelines: Liver transplantation.

Authors: 
Journal:  J Hepatol       Date:  2015-11-17       Impact factor: 25.083

2.  The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.

Authors:  D E Schaubel; C S Sima; N P Goodrich; S Feng; R M Merion
Journal:  Am J Transplant       Date:  2008-01-07       Impact factor: 8.086

3.  Steatotic livers for liver transplantation--life-saving but at a cost.

Authors:  Sandy Feng
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-05-20

4.  Putting objectivity into assessment of steatosis.

Authors:  Michael A Silva
Journal:  Transplantation       Date:  2009-09-15       Impact factor: 4.939

5.  Liver biopsy in assessment of extended criteria donors.

Authors:  Joseph B Oliver; Praveena Machineni; Advaith Bongu; Trusha Patel; Joseph Nespral; Carie Kadric; Michael J Goldstein; Harvey Lerner; David Gee; Richard Hillbom; Lloyd Brown; Kenneth Washburn; Baburao Koneru
Journal:  Liver Transpl       Date:  2018-02       Impact factor: 5.799

6.  The optimal number of donor biopsy sites to evaluate liver histology for transplantation.

Authors:  Wendy L Frankel; Jason G Tranovich; Laura Salter; Ginny Bumgardner; Peter Baker
Journal:  Liver Transpl       Date:  2002-11       Impact factor: 5.799

7.  Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

Authors:  J F Cadranel; P Rufat; F Degos
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

8.  Frozen section evaluation of donor livers before transplantation.

Authors:  R S Markin; J L Wisecarver; S J Radio; R J Stratta; A N Langnas; K Hirst; B W Shaw
Journal:  Transplantation       Date:  1993-12       Impact factor: 4.939

9.  The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation.

Authors:  A M D'Alessandro; M Kalayoglu; H W Sollinger; R M Hoffmann; A Reed; S J Knechtle; J D Pirsch; G R Hafez; D Lorentzen; F O Belzer
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

Review 10.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.